Inflammatory Bowel DiseasesGut health
What this study is
This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for IBD in a cohort of patients cared for by gastroenterologists across North America. Secondary objectives include analyzing the epidemiology and natural history of the disease, its comorbidities, and current treatment practices.
Study details
- Sponsor
- CorEvitas
- Conditions
- Inflammatory Bowel Diseases
- Enrolling
- 2,287 people
- Starts
- 2017-03-27
- Est. completion
- 2100-12
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- ELIGIBILITY CRITERIA∗ To be eligible for enrollment into the CorEvitas IBD Registry, a patient must satisfy all of the inclusion criteria and none of the exclusion criteria listed below.
- At least 18 years of age or older.
- Willing and able to provide written consent for participation in the IBD Registry.
- Willing and able to provide Personally Identifiable Information (PII) which includes the following types of personal information at a minimum: full name, date of birth, sex, and home address zip code.
- Diagnosis of one of the following by a gastroenterologist:; Crohn's disease; Ulcerative colitis
- Prevalent users or new /incident users of an approved biologic drug or JAK inhibitor (Tofacitinib) for the treatment of UC or Crohn's disease.
You can't join if
- Participating in or planning to participate in a clinical trial (Phase I - III) or a post-marketing study or registry (i.e. phase IV).∆
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openCorEvitas, LLC
Waltham, Massachusetts, United States
Study team
Sponsor
CorEvitas
Study ID CorEvitas-IBD-600
Study director
Jeffrey Greenberg, MD
CorEvitas, LLC
Have questions? The record lists no central contact. Use Consider me and the site team can reach you, or find them through ClinicalTrials.gov ↗.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.